Stay updated with breaking news from Nasdaq Eldn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright restated their buy rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a $13.00 price objective on the stock. Eledon Pharmaceuticals Stock Performance Shares of NASDAQ ELDN opened at $2.07 on Friday. The firm’s 50-day simple moving average […]
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2024 earnings estimates for shares of Eledon Pharmaceuticals in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.33) per share for the quarter. The consensus estimate for Eledon […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 65,300 shares, a growth of 147.3% from the November 30th total of 26,400 shares. Based on an average daily volume of 97,400 shares, […]
Eledon Pharmaceuticals (NASDAQ:ELDN – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report released on Monday, Benzinga reports. They currently have a $13.00 target price on the stock. Several other brokerages have also weighed in on ELDN. Noble Financial initiated coverage on shares of Eledon Pharmaceuticals in a report […]